<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="anthelminthic/PMC5371198/results/search/disease/results.xml">
  <result pre="pmcid: 5371198 pmid: 28351414286 doi: 10.1186/s40249-017-0286-2 : Scoping Review Controlling" exact="schistosomiasis" post="with praziquantel: How much longer without a viable alternative?"/>
  <result pre="properties in plants. Here, we summarise recent progress made in" exact="schistosomiasis" post="chemotherapy, placing particular emphasis on repositioning of existing drugs"/>
  <result pre="a disease of poverty [3, 4]. The global burden of" exact="schistosomiasis" post="is estimated at 2.6 million disability-adjusted life years (DALYs)"/>
  <result pre="days lost annually is far below those calculated for HIV/AIDS," exact="malaria" post="and tuberculosis, the perceived importance of schistosomiasis is now"/>
  <result pre="calculated for HIV/AIDS, malaria and tuberculosis, the perceived importance of" exact="schistosomiasis" post="is now more realistic than 10–15 years ago. Indeed,"/>
  <result pre="previously counted by the Global Burden of Disease (GBD) study," exact="schistosomiasis" post="now comes second on the list of 18 (after"/>
  <result pre="Cambodia and Lao People’s Democratic Republic [14]. The pathology characterising" exact="schistosomiasis" post="is primarily the result of immune responses against schistosome"/>
  <result pre="diagnosis [16]. A systematic review and geostatistical analysis pertaining to" exact="schistosomiasis" post="in sub-Saharan Africa suggests that the prevalence and distribution"/>
  <result pre="spectrum against helminth infections, remains the drug of choice for" exact="schistosomiasis" post="chemotherapy since almost 40 years [18, 19]. Thanks to"/>
  <result pre="various ailments since ancient times marked the end of non-specific" exact="schistosomiasis" post="chemotherapy [27, 28]. Schistosomiasis control is at a pivotal"/>
  <result pre="road map for the global control of the NTDs includes" exact="schistosomiasis" post="[30]. However, control – let alone elimination – of"/>
  <result pre="schistosomiasis [30]. However, control – let alone elimination – of" exact="schistosomiasis" post="has proven difficult because of rapid re-infection due to"/>
  <result pre="not dwindle, particularly not in low- and middle-income countries where" exact="schistosomiasis" post="inflicts a disproportionately high burden of disease. Judging from"/>
  <result pre="Judging from the veterinary field, development of drug resistance in" exact="helminthiasis" post="can be swift [35] and the situation with respect"/>
  <result pre="can be swift [35] and the situation with respect to" exact="malaria" post="is a constant reminder of this risk [36]. Laboratory"/>
  <result pre="risk [36]. Laboratory studies The search for new drugs against" exact="schistosomiasis" post="has taken various directions, including testing natural compounds, target-based"/>
  <result pre="also contain compounds with such effect, notably drugs used for" exact="cancer" post="therapy [51]. Table 1 contains a list of candidate"/>
  <result pre="drugs described in some detail with regard to use against" exact="schistosomiasis" post="summarising their effect on adult and juvenile schistosomes, including"/>
  <result pre="played a major role in drug discovery, in particular for" exact="malaria" post="treatment and prophylaxis. While quinine and artemisinin come straight"/>
  <result pre="deemed a strong indication of a novel drug lead for" exact="schistosomiasis" post="[74]. Anticancer drugs It has further been demonstrated that"/>
  <result pre="has so far mainly been used in the treatment of" exact="chronic lymphocytic leukemia," post="low-grade non-Hodgkin’s lymphoma and Hodgkin’s disease, and is on"/>
  <result pre="used in the treatment of chronic lymphocytic leukemia, low-grade non-Hodgkin’s" exact="lymphoma" post="and Hodgkin’s disease, and is on the WHO list"/>
  <result pre="only to reproduction processes, but also to the pathology of" exact="schistosomiasis" post="[79]. Kinases represent therefore attractive targets for new-generation antischistosomal"/>
  <result pre="the plant Artemisia annua recommended in Chinese traditional medicine against" exact="malaria" post="(and other ailments), constituted the starting point for the"/>
  <result pre="including the artemisinins along with praziquantel in areas endemic for" exact="schistosomiasis" post="and co-endemic for malaria [88, 90]. In more detail,"/>
  <result pre="with praziquantel in areas endemic for schistosomiasis and co-endemic for" exact="malaria" post="[88, 90]. In more detail, the antischistosomal effect of"/>
  <result pre="artesunate, however, must be taken seriously as the emergence of" exact="malaria" post="parasites resistant to the artemisinins have shown [99, 100]."/>
  <result pre="assessed as an alternative to ivermectin in the treatment of" exact="onchocerciasis" post="in humans. In the frame of this programme its"/>
  <result pre="the treatment of domestic animals in the context of zoonotic" exact="schistosomiasis" post="[115], increases the risk for development of resistance and"/>
  <result pre="we are still years from potential field application of a" exact="schistosomiasis" post="vaccine. In addition, new drugs are an unconditional necessity"/>
  <result pre="a landmark in the advance towards completely new drugs against" exact="schistosomiasis" post="(and also malaria), ongoing research on repositioning existing drugs"/>
  <result pre="alternatives to praziquantel are necessary for sustaining the control of" exact="schistosomiasis" post="and approaching the goal of eliminating this scourge from"/>
  <result pre="integrated control of schistosomiasisActa Trop2011120Suppl 1S1213710.1016/j.actatropica.2010.08.02020831855 10.LaiYSBiedermannPEkpoUFGarbaAMathieuEMidziNMwinziPN’GoranEKRasoGAssaréRKet al.Spatial distribution of" exact="schistosomiasis" post="and treatment needs in sub-Saharan Africa: a systematic review"/>
  <result pre="review and geostatistical analysisLancet Infect Dis20151589274010.1016/S1473-3099(15)00066-326004859 11.ScholteRGCGosoniuLMaloneJBChammartinFUtzingerJVounatsouPPredictive risk mapping of" exact="schistosomiasis" post="in Brazil using Bayesian geostatistical modelsActa Trop2014132576310.1016/j.actatropica.2013.12.00724361640 12.UtzingerJBergquistROlvedaRZhouXNImportant helminth"/>
  <result pre="27.ShekharKCSchistosomiasis drug therapy and treatment considerationsDrugs199142337940510.2165/00003495-199142030-000041720380 28.KnoppSBeckerSLIngramKJKeiserJUtzingerJDiagnosis and treatment of" exact="schistosomiasis" post="in children in the era of intensified controlExpert Rev"/>
  <result pre="Infect Ther2013111112375810.1586/14787210.2013.84406624127662 29.RollinsonDKnoppSLevitzSStothardJRTchuem TchuentéLAGarbaAMohammedKASchurNPersonBColleyDGet al.Time to set the agenda for" exact="schistosomiasis" post="eliminationActa Trop201312824234010.1016/j.actatropica.2012.04.01322580511 30.collab: WHOAccelerating work to overcome the global"/>
  <result pre="review and meta-analysisPLoS Negl Trop Dis201481210.1371/journal.pntd.000329625474705 32.SokolowSHWoodCLJonesIJSwartzSJLopezMHsiehMHLaffertyKDKurisAMRickardsCDe LeoGAGlobal assessment of" exact="schistosomiasis" post="control over the past century shows targeting the snail"/>
  <result pre="sequence of Schistosoma haematobiumNat Genet2012442221510.1038/ng.106522246508 47.FerreiraLGOlivaGAndricopuloADTarget-based molecular modeling strategies for" exact="schistosomiasis" post="drug discoveryFuture Med Chem2015767536410.4155/fmc.15.2125996068 48.WebsterJPOlivieraGRollinsonDGowerCMSchistosome genomes: a wealth of"/>
  <result pre="Infect Dis200865253810.1016/j.tmaid.2008.06.00618760248 64.SchlagenhaufPAdamcovaMRegepLSchaererMTRheinHGThe position of mefloquine as a 21st century" exact="malaria" post="chemoprophylaxisMalar J2010935710.1186/1475-2875-9-35721143906 65.KeiserJCholletJXiaoSHMeiJYJiaoPYUtzingerJTannerMMefloquine-an aminoalcohol with promising antischistosomal properties in"/>
  <result pre="71.Ingram-SieberKCowanNPanicGVargasMMansourNRBickleQDWellsTNSpangenbergTKeiserJOrally active antischistosomal early leads identified from the open access" exact="malaria" post="boxPLoS Negl Trop Dis20148110.1371/journal.pntd.000261024416463 72.CowanNDatwylerPErnstBWangCVennerstromJLSpangenbergTKeiserJActivities of N, N’-Diarylurea MMV665852"/>
  <result pre="metal complexesAntimicrob Agents Chemother20166095331610.1128/AAC.00778-1627324765 75.EissaMMEl-AzzouniMZAmerEIBaddourNMMiltefosine, a promising novel agent for" exact="schistosomiasis" post="mansoniInt J Parasitol20114122354210.1016/j.ijpara.2010.09.01021055404 76.El-MoslemanyRMEissaMMRamadanAAEl-KhordaguiLKEl-AzzouniMZMiltefosine lipid nanocapsules: intersection of drug"/>
  <result pre="repurposing and nanotechnology for single dose oral treatment of pre-patent" exact="schistosomiasis" post="mansoniActa Trop2016159142810.1016/j.actatropica.2016.03.03827039667 77.EissaMMMossallamSFAmerEIYounisLKRashedHARepositioning of chlorambucil as a potential anti-schistosomal"/>
  <result pre="chemoprophylaxis of major human schistosome parasitesCurr Med Chem200181518416010.2174/092986701337158111772354 87.UtzingerJXiaoSHTannerMKeiserJArtemisinins for" exact="schistosomiasis" post="and beyondCurr Opin Investig Drugs2007821051617328226 88.UtzingerJTannerMKeiserJACTs for schistosomiasis: do"/>
  <result pre="in Plasmodium falciparumCurr Opin Infect Dis2011246570710.1097/QCO.0b013e32834cd3ed22001944 100.TaylorSMJulianoJJArtemisinin combination therapies and" exact="malaria" post="parasite drug resistance: the game is afootJ Infect Dis20142103335710.1093/infdis/jiu14224610873"/>
  <result pre="is afootJ Infect Dis20142103335710.1093/infdis/jiu14224610873 101.ElmorshedyHTannerMBergquistRNSharafSBarakatRProphylactic effect of artemether on human" exact="schistosomiasis" post="mansoni among Egyptian children: a randomized controlled trialActa Trop201615852810.1016/j.actatropica.2016.02.01526921676"/>
  <result pre="107.AwadziKOpokuNOAttahSKLazdins-HeldsJKueselACA randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca" exact="volvulus" post="infectionPLoS Negl Trop Dis20148610.1371/journal.pntd.000295324968000 108.SelimSEl SagheerOEl AmirABarakatRHadleyKBruinsMJEl RidiREfficacy and"/>
  <result pre="Parasitol200319115091510.1016/j.pt.2003.09.00514580962 111.LoNCAddissDGHotezPJKingCHStothardJREvansDSColleyDGLinWCoulibalyJTBustinduyALet al.A call to strengthen the global strategy against" exact="schistosomiasis" post="and soil-transmitted helminthiasis: the time is nowLancet Infect Dis2017172e64910.1016/S1473-3099(16)30535-727914852"/>
  <result pre="al.Efficacy and safety of praziquantel for the treatment of human" exact="schistosomiasis" post="during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trialLancet"/>
  <result pre="in schools and communities targeted for the elimination of urogenital" exact="schistosomiasis" post="in Zanzibar: a cross-sectional surveyParasit Vectors20169510.1186/s13071-015-1244-026727915 115.HongQBYangKHuangYXSunLPYangGJGaoYGaoYZhangLHZhouMSteinmannPet al.Effectiveness of"/>
  <result pre="Zanzibar: a cross-sectional surveyParasit Vectors20169510.1186/s13071-015-1244-026727915 115.HongQBYangKHuangYXSunLPYangGJGaoYGaoYZhangLHZhouMSteinmannPet al.Effectiveness of a comprehensive" exact="schistosomiasis" post="japonica control program in Jiangsu province, China, from 2005"/>
  <result pre="1S151710.1016/j.actatropica.2010.11.00621147056 116.BergquistRUtzingerJMcManusDPTrick or treat: the role of vaccines in integrated" exact="schistosomiasis" post="controlPLoS Negl Trop Dis20082610.1371/journal.pntd.000024418575619 117.TebejeBMHarvieMYouHLoukasAMcManusDPSchistosomiasis vaccines: where do we"/>
 </snippets>
</snippetsTree>
